✦ LIBER ✦

Systemic adjuvant treatment of high-risk melanoma: the role of interferon Alfa-2b and other immunotherapies

✍ Scribed by J.M Kirkwood

Book ID: 117664221
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 112 KB
Volume: 34
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(97)10159-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Severe loss of vision during adjuvant in

Severe loss of vision during adjuvant interferon alfa-2b treatment for malignant melanoma

✍ Chris P Lohmann; Gisela Kroher; Thomas Bogenrieder; Detlev Spiegel; Jürgen Preun 📂 Article 📅 1999 🏛 The Lancet 🌐 English ⚖ 61 KB

Cost-effectiveness assessment of interfe

Cost-effectiveness assessment of interferon alfa-2b as adjuvant therapy of high-risk resected cutaneous melanoma

✍ B.E Hillner 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 62 KB

4LB Results of the Nordic randomised adj

4LB Results of the Nordic randomised adjuvant trial of intermediate-dose interferon alfa-2b in high-risk melanoma

✍ J. Hansson; S. Aamdal; L. Bastholt; M. Hernberg; B. Nilsson; U. Stierner; H. von 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Interferon Alfa-2b or Not 2b? Significan

Interferon Alfa-2b or Not 2b? Significant Differences Exist in the Decision-Making Process between Melanoma Patients Who Accept or Decline High-Dose Adjuvant Interferon Alfa-2b Treatment

✍ TRACY B. BRAMLETTE; DAVID H. LAWSON; CARL V. WASHINGTON; EMIR VELEDAR; BARRY R. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB

PP34. Economic analysis of adjuvant inte

PP34. Economic analysis of adjuvant interferon-ALFA 2B (IFN) in high risk melanoma using projections from ECOG (E) 1684

✍ BE Hillner; JM Kirkwood; MB Atkins; ER Johnson; TJ Smith 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 147 KB

The feasibility of adjuvant interferon α

The feasibility of adjuvant interferon α-2b in children with high-risk melanoma

✍ Fariba Navid; Wayne L. Furman; Martin Fleming; Bhaskar N. Rao; Sandra Kovach; Ca 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

## Abstract ## BACKGROUND It has been shown that induction high‐dose interferon α‐2b (IFN‐α‐2b) followed by maintenance therapy improves recurrence‐free survival in adults with high‐risk, resected melanoma. In this study, the feasibility and toxicity of this regimen were evaluated in newly diagnos